[1]
L. I. Kucherenko and V. H. Slobodianyk, “The relevance of creating a new combination drug for the treatment of cognitive disorders”, Current issues in pharmacy and medicine: science and practice, vol. 18, no. 2, pp. 206–214, Jul. 2025.